Marshall Wace
ACHC icon

Marshall Wace’s Acadia Healthcare ACHC Stock Holding History

Marshall Wace’s Portfolio ACHC Stock Details ACHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.49M Sell
149,196
-321,197
-68% -$5.81M ﹤0.01% 1491
2025
Q4 		$6.67M Buy
470,393
+359,670
+325% +$6.81M 0.01% 1027
2025
Q3 		$2.74M Buy
+110,723
New +$2.47M ﹤0.01% 1469
2025
Q2 		– Sell
-50,260
Closed -$1.52M – 2640
2025
Q1 		$1.52M Sell
50,260
-330,131
-87% -$12.6M ﹤0.01% 1589
2024
Q4 		$15.1M Buy
380,391
+128,142
+51% +$5.78M 0.02% 642
2024
Q3 		$16M Buy
252,249
+98,724
+64% +$7.13M 0.02% 586
2024
Q2 		$10.4M Buy
153,525
+117,642
+328% +$8.22M 0.01% 712
2024
Q1 		$2.84M Buy
+35,883
New +$2.93M ﹤0.01% 1220
2023
Q1 		– Sell
-15,758
Closed -$1.3M – 2591
2022
Q4 		$1.3M Sell
15,758
-707
-4% -$58.3K ﹤0.01% 1961
2022
Q3 		$1.29M Buy
+16,465
New +$1.32M ﹤0.01% 2282
2021
Q3 		– Sell
-15,913
Closed -$999K – 2964
2021
Q2 		$999K Sell
15,913
-8,118
-34% -$509K ﹤0.01% 1807
2021
Q1 		$1.37M Buy
24,031
+14,485
+152% +$784K 0.01% 1502
2020
Q4 		$480K Buy
+9,546
New +$380K ﹤0.01% 1470
2020
Q1 		– Sell
-265,492
Closed -$8.82M – 1588
2019
Q4 		$8.82M Buy
+265,492
New +$8.32M 0.06% 343
2018
Q2 		– Sell
-15,925
Closed -$624K – 687
2018
Q1 		$624K Hold
15,925
– – 0.03% 319
2017
Q4 		$520K Buy
+15,925
New +$552K 0.02% 290
2017
Q2 		– Sell
-48,035
Closed -$2.11M – 302
2017
Q1 		$2.11M Buy
+48,035
New +$1.95M 0.1% 131
2016
Q4 		– Sell
-131,755
Closed -$6.53M – 951
2016
Q3 		$6.53M Buy
+131,755
New +$6.86M 0.05% 353
2015
Q3 		– Sell
-78,158
Closed -$6.12M – 890
2015
Q2 		$6.12M Sell
78,158
-32,545
-29% -$2.34M 0.08% 267
2015
Q1 		$7.93M Sell
110,703
-5,030
-4% -$323K 0.1% 233
2014
Q4 		$7.08M Buy
115,733
+73,306
+173% +$4.27M 0.09% 242
2014
Q3 		$2.06M Buy
+42,427
New +$2.07M 0.03% 440

Other funds holding ACHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ABI
Abrams Bison Investments Bethesda, Maryland $2.31B AUM 40.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Marshall Wace's ACHC Position: Q1 2026 in Review

Marshall Wace reduced its Acadia Healthcare (ACHC) stake by 68% in Q1 2026, selling an estimated $5.81M and leaving 149,196 shares worth $3.49M. The position accounts for ﹤0.01% of the portfolio, ranked #1491.

Marshall Wace first reported a position in ACHC in Q3 2014 and has held it in 22 quarters since. The position peaked at $16M in Q3 2024. 295 funds tracked by Wall St. Rank hold ACHC as of Q1 2026.

  • Marshall Wace held 149,196 shares of Acadia Healthcare worth $3.49M as of Q1 2026.
  • Marshall Wace sold 321,197 Acadia Healthcare shares in Q1 2026, an estimated $5.81M.
  • Acadia Healthcare made up ﹤0.01% of Marshall Wace's portfolio in Q1 2026, its #1491 holding.
  • Marshall Wace first reported a position in Acadia Healthcare in Q3 2014 and has held it in 22 quarters since.
  • Marshall Wace's Acadia Healthcare position peaked at $16M in Q3 2024.
  • 295 funds tracked by Wall St. Rank held Acadia Healthcare as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.